Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...

Antibodies, which recognize viruses and proteins that the body has encountered before, have long gotten most of the credit ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...

During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that are expressed by cells of the body.

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

A study conducted by researchers from São Paulo State University (UNESP), in Brazil, and collaborators shows that lemon ...

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to ...